167 related articles for article (PubMed ID: 30691173)
1. Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core.
Rybka JD; Mieloch AA; Plis A; Pyrski M; Pniewski T; Giersig M
Nanomaterials (Basel); 2019 Jan; 9(2):. PubMed ID: 30691173
[TBL] [Abstract][Full Text] [Related]
2. Efficient Production of Chimeric Hepatitis B Virus-Like Particles Bearing an Epitope of Hepatitis E Virus Capsid by Transient Expression in
Zahmanova G; Mazalovska M; Takova K; Toneva V; Minkov I; Peyret H; Lomonossoff G
Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33477348
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
Liu D; Li B; Bi C; Qiao H; Wu X
Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
5. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
[TBL] [Abstract][Full Text] [Related]
6. Preparation and preliminary evaluation of hepatitis B core antigen virus like nanoparticles loaded with indocyanine green.
Wang Y; Zhang Y; Yu Y; Ren L; Wang J; Cheng L; Jiang D; Guo X; Teng T; Luo X; Lv S; Wang X; Wang H; Shi X; Zhang H; Bi S
Ann Transl Med; 2020 Dec; 8(24):1661. PubMed ID: 33490173
[TBL] [Abstract][Full Text] [Related]
7. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
[TBL] [Abstract][Full Text] [Related]
8. Cost-effective purification process development for chimeric hepatitis B core (HBc) virus-like particles assisted by molecular dynamic simulation.
Zhang B; Yin S; Wang Y; Su Z; Bi J
Eng Life Sci; 2021 Jun; 21(6):438-452. PubMed ID: 34140854
[TBL] [Abstract][Full Text] [Related]
9. Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours.
Suffian IFBM; Al-Jamal KT
Adv Drug Deliv Rev; 2022 Jan; 180():114030. PubMed ID: 34736988
[TBL] [Abstract][Full Text] [Related]
10. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.
Moradi Vahdat M; Hemmati F; Ghorbani A; Rutkowska D; Afsharifar A; Eskandari MH; Rezaei N; Niazi A
Biotechnol Rep (Amst); 2021 Mar; 29():e00605. PubMed ID: 33732633
[TBL] [Abstract][Full Text] [Related]
12. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation.
Ludgate L; Liu K; Luckenbaugh L; Streck N; Eng S; Voitenleitner C; Delaney WE; Hu J
J Virol; 2016 Jun; 90(12):5830-5844. PubMed ID: 27076641
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
15. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
Strods A; Ose V; Bogans J; Cielens I; Kalnins G; Radovica I; Kazaks A; Pumpens P; Renhofa R
Sci Rep; 2015 Jun; 5():11639. PubMed ID: 26113394
[TBL] [Abstract][Full Text] [Related]
16. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid.
Tordjeman M; Fontan G; Rabillon V; Martin J; Trepo C; Hoffenbach A; Mabrouk K; Sabatier JM; Van Rietschoten J; Somme G
J Med Virol; 1993 Nov; 41(3):221-9. PubMed ID: 7505307
[TBL] [Abstract][Full Text] [Related]
17. Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.
Kazaks A; Lu IN; Farinelle S; Ramirez A; Crescente V; Blaha B; Ogonah O; Mukhopadhyay T; de Obanos MP; Krimer A; Akopjana I; Bogans J; Ose V; Kirsteina A; Kazaka T; Stonehouse NJ; Rowlands DJ; Muller CP; Tars K; Rosenberg WM
BMC Biotechnol; 2017 Nov; 17(1):79. PubMed ID: 29126399
[TBL] [Abstract][Full Text] [Related]
18. Expression and self-assembly in baculovirus of porcine enteric calicivirus capsids into virus-like particles and their use in an enzyme-linked immunosorbent assay for antibody detection in swine.
Guo M; Qian Y; Chang KO; Saif LJ
J Clin Microbiol; 2001 Apr; 39(4):1487-93. PubMed ID: 11283075
[TBL] [Abstract][Full Text] [Related]
19. Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system.
Armero-Gimenez J; Wilbers R; Schots A; Williams C; Finnern R
Front Immunol; 2023; 14():1088852. PubMed ID: 36776898
[TBL] [Abstract][Full Text] [Related]
20. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.
Schumacher J; Bacic T; Staritzbichler R; Daneschdar M; Klamp T; Arnold P; Jägle S; Türeci Ö; Markl J; Sahin U
J Nanobiotechnology; 2018 Apr; 16(1):39. PubMed ID: 29653575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
